264 related articles for article (PubMed ID: 21907395)
1. Filling the gap between science & clinical practice: prevention of stroke recurrence.
Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
[TBL] [Abstract][Full Text] [Related]
2. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
3. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
4. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
Weber R; Weimar C; Diener HC
Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
[TBL] [Abstract][Full Text] [Related]
5. Cardioembolic stroke: call for a multidisciplinary approach.
Babarro EG; Rego AR; González-Juanatey JR
Cerebrovasc Dis; 2009; 27 Suppl 1():82-7. PubMed ID: 19342836
[TBL] [Abstract][Full Text] [Related]
6. New anti-thrombotic drugs for stroke prevention.
Di Minno MN; Russolillo A; Camera M; Brambilla M; De Gregorio A; Tremoli E; Di Minno G
Curr Vasc Pharmacol; 2011 Nov; 9(6):723-32. PubMed ID: 21143164
[TBL] [Abstract][Full Text] [Related]
7. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
Peterson GM; Boom K; Jackson SL; Vial JH
Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
9. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents in stroke prevention: acute and long-term treatment strategies.
Weber R; Weimar C; Diener HC
Hamostaseologie; 2009 Nov; 29(4):326-33. PubMed ID: 19882077
[TBL] [Abstract][Full Text] [Related]
11. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
12. Preventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: the current data.
Bergman D
J Am Acad Nurse Pract; 2011 Dec; 23(12):659-66. PubMed ID: 22145656
[TBL] [Abstract][Full Text] [Related]
13. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic interventions for prevention of recurrent ischemic stroke.
Kirshner HS
Am J Manag Care; 2008 Jun; 14(6 Suppl 2):S212-26. PubMed ID: 18611103
[TBL] [Abstract][Full Text] [Related]
15. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
16. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
17. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards.
Marcucci M; Iorio A; Nobili A; Tettamanti M; Pasina L; Marengoni A; Salerno F; Corrao S; Mannucci PM;
Eur J Intern Med; 2010 Dec; 21(6):516-23. PubMed ID: 21111937
[TBL] [Abstract][Full Text] [Related]
18. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
19. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
[TBL] [Abstract][Full Text] [Related]
20. [A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].
Ma RH; Wang YJ; Wang CX; Zhao XQ; Wang YL; Xu MJ; Wei M; Li Y; Zhang Z; Zhang WW; Wang L; Lin L; Li HT; Zheng T; Wang XW; Li JJ; Lü Y; Qi D
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2618-22. PubMed ID: 19080709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
